Why Oncology Imaging Review Breaks Down
Oncology imaging is rarely just an image. It carries symptoms, timing, prior studies, pathology, molecular findings, treatment constraints, and a person waiting for clarity.
The pressure becomes sharper in aggressive cancer contexts, where late answers can narrow the window for meaningful options.
TumorQ is NEXQ’s response to that fragmentation: a governed review workflow that keeps imaging, evidence, and care-plan context together for professional review.
The Human Reason Behind TumorQ
TumorQ's origin story is deeply personal. Michelle L. Wu describes being shaped by family loss, late-stage cancer diagnoses among people close to her, and the emotional cost of delayed diagnoses and ineffective treatments.
Her undergraduate work at UC Riverside, mentorship from experts at institutions including UC Berkeley and MIT, and research exposure through City of Hope helped form the interdisciplinary foundation behind NEXQ's oncology direction.
The article frames TumorQ as a bridge between quantum technology and medical science, with encryption and privacy presented as non-negotiable alongside clinical innovation.
The Technical Direction
TumorQ explores quantum and AI-assisted modeling methods for complex medical datasets, including glioma MRI research references such as BraTS2020.
Any accuracy, segmentation, or real-time analytics claim requires a claim ID, locked model version, dataset description, validation protocol, limitations, uncertainty analysis, and regulatory-status note before publication.
Sensitive information workflows require approved contracts, privacy/security review, documented controls, retention rules, and role-based access before processing.
Mission and Vision
The vision for TumorQ centers on patient-centered care where precision, speed, and compassion work together rather than in tension.
NEXQ positions TumorQ as part of a governed oncology research and professional-review workflow direction, subject to clinical, legal, and technical validation.